Cargando…
How difficult is the validation of clinical biomarkers?
Recent developments of introducing stratified medicine/personal health care have led to an increased demand for specific biomarkers. However, despite the myriads of biomarkers claimed to be fit for all sorts of diseases and applications, the scientific integrity of the claims and therefore their cre...
Autor principal: | Voskuil, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431379/ https://www.ncbi.nlm.nih.gov/pubmed/26069732 http://dx.doi.org/10.12688/f1000research.6395.1 |
Ejemplares similares
-
The challenges with the validation of research antibodies
por: Voskuil, Jan L.A.
Publicado: (2017) -
Commercial antibodies and their validation
por: Voskuil, JLA
Publicado: (2014) -
The Cutaneous Physiological Redox: Essential to Maintain but Difficult to Define
por: Ron-Doitch, Sapir, et al.
Publicado: (2020) -
Gestation-Based Viability–Difficult Decisions with Far-Reaching Consequences
por: Thomas, Sumesh, et al.
Publicado: (2021) -
Lots of Lovely Numbers, but Why Does Everyone Make It So Difficult?
por: Pullinger, John
Publicado: (2020)